TISSUE GLYCOGEN LEVELS IN ANIMALS TREATED WITH THE AMINONUCLEOSIDE OF PUROMYCIN.
D001786:Blood Glucose; D050260:Carbohydrate Metabolism; D005215:Fasting; D005947:Glucose / Q000378:metabolism*; D005952:Glucose-6-Phosphatase; D006003:Glycogen; D007668:Kidney; D008112:Liver Glycogen; D009132:Muscles; D009404:Nephrotic Syndrome; D009705:Nucleosides; D010600:Pharmacology; D011691:Puromycin; D011692:Puromycin Aminonucleoside; D011817:Rabbits; D051381:Rats; D012106:Research
D001786:Blood Glucose; D008112:Liver Glycogen; D009705:Nucleosides; D011691:Puromycin; D011692:Puromycin Aminonucleoside; D006003:Glycogen; D005952:Glucose-6-Phosphatase; D005947:Glucose
BLOOD SUGAR; CARBOHYDRATE METABOLISM; EXPERIMENTAL LAB STUDY; FASTING; GLUCOSE METABOLISM; GLUCOSEPHOSPHATASE; GLYCOGEN; KIDNEY; LIVER GLYCOGEN; MUSCLES; NEPHROTIC SYNDROME; NUCLEOSIDES; PHARMACOLOGY; PUROMYCIN; RABBITS; RATS